SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-015538
Filing Date
2020-04-06
Accepted
2020-04-06 16:53:52
Documents
5
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A vir-defa14a_20200406.htm DEFA14A 32308
2 GRAPHIC gt5ohvljwywx000002.jpg GRAPHIC 78192
3 GRAPHIC gt5ohvljwywx000003.jpg GRAPHIC 15542
4 GRAPHIC gt5ohvljwywx000001.jpg GRAPHIC 41476
5 GRAPHIC gt5ohvljwywx000004.jpg GRAPHIC 7537
  Complete submission text file 0001564590-20-015538.txt   230512
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39083 | Film No.: 20777560
SIC: 2836 Biological Products, (No Diagnostic Substances)